ONYEBUCHI OGBO: Open Payments
NPI 1982247524 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,154 in 82 payments from 14 companies in 2025. Trend: 2023 $1,789 · 2024 $1,111 · 2025 $2,154
Food & beverage: $1,979Education: $175
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $346 |
| Otsuka America Pharmaceutical, Inc. | 11 | $343 |
| ABBVIE INC. | 11 | $283 |
| E.R. Squibb & Sons, L.L.C. | 6 | $244 |
| Axsome Therapeutics, Inc. | 9 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $186 |
| Janssen Pharmaceuticals, Inc | 5 | $131 |
| Neurocrine BioSciences, Inc. | 4 | $94 |
| Lundbeck LLC | 4 | $87 |
| Alkermes, Inc. | 3 | $70 |
Products named: REXULTI, VRAYLAR, COBENFY, Auvelity, CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, INGREZZA.
Industry payments across MA — which companies pay providers there.
